Nathanael S. Gray

Publishes on Lung Cancer Treatments and Mutations, Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways. 1.5k papers and 86.3k citations.

PubIndex Score98Top 2%How it's scored

🌟#6 Current Senior Leader in Quinazolinone synthesis and applications 🌟#7 Current Senior Leader in Protein Degradation and Inhibitors

1.5kPublications

86.3kTotal Citations

#6in Quinazolinone synthesis and applications

First publication: 1968First senior author: 2001

Lung Cancer Treatments and Mutations Protein Degradation and Inhibitors Ubiquitin and proteasome pathways Melanoma and MAPK Pathways RNA modifications and cancer

Top publicationsby citations

Systematic identification of genomic markers of drug sensitivity in cancer cells

Mathew J. Garnett, Daniel A. Haber, Laura Richardson et al.|Nature|2012

Cited by 2.6k

A Landscape of Pharmacogenomic Interactions in Cancer

Francesco Iorio, Mathew J. Garnett, Theo Knijnenburg et al.|Cell|2016

Cited by 2.3k

An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1

Carson C. Thoreen, Nathanael S. Gray|Journal of Biological Chemistry|2009

Cited by 1.8k

The promise and peril of chemical probes

C.H. Arrowsmith, Michael A. Walters, James E. Audia et al.|Nature Chemical Biology|2015

Cited by 848

Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate

Marta Sanna, Hugh Rosen, Jiayu Liao et al.|Journal of Biological Chemistry|2004

Cited by 621